New model for hard-to-study form of blindness paves way for future research

September 6, 2017
Credit: University of Rochester Medical Center

Macular degeneration is the leading cause of vision loss in older adults, but scientists have long struggled to study and replicate key elements of the disease in the lab. A study published in the Proceedings of the National Academy of Sciences is the first to demonstrate hallmarks of macular degeneration in a new human stem cell model developed by researchers at the University of Rochester Medical Center.

This new model could make whole new avenues of macular degeneration research possible and has helped the team hone in on some possible drug targets for the disease.

"So far, there has not been a patient-derived model of macular degeneration," said Ruchira Singh, Ph.D., assistant professor of Ophthalmology in the Flaum Eye Institute at URMC and lead author of the study. "It was not known if you can take cells from the human eye and make a cell model that displays the hallmarks of the disease."

Though macular diseases can vary widely, age-related and similar inherited macular degenerative diseases are all characterized by buildup of debris in the retina, the light sensing tissue in the back of the eye that is crucial for vision. These deposits, called drusen, are specifically found beneath a layer of retinal pigment epithelium (RPE) cells, which are known to be key players in macular degeneration.

For their new model, Singh's team collected from patients with genetic forms of macular degeneration, re-programmed them to , and used the stem cells to create RPE cells. RPE cells derived from patients mimicked several characteristics of macular degeneration when aged in a dish, like producing the hallmark deposits.

RPE cells carrying macular degeneration-causing mutations developed more deposits with more similar composition to what is seen in the affected human eye than cells from healthy adults, or patients' cells in which disease-causing mutations were corrected using gene editing.

Using this model, Singh's group showed for the first time that dysfunctional RPE cells can cause specific aspects of macular degeneration on their own - without the help of other cells or components of the retina. This was true for cells derived from patients with three different genetic forms of macular degeneration, suggesting RPE cell dysfunction could be central to multiple forms of the disease.

Singh's also allowed her research team to identify a group of molecules in RPE cells that could be targeted by new macular degeneration drugs. These "complement proteins", which normally boost immune functions in cells, may be affected by genetic alterations that cause macular degeneration. In the study, the expression of genes that encode these proteins was elevated in RPE cells from all of the macular degeneration patients, suggesting they may also play a key role in multiple forms of the disease.

"Now we can actually identify and test a rational drug therapy in patients' own cells," said Singh. "So far, this has not been possible, but now we can actually study macular diseases in parallel and identify what might be the central defect across macular diseases."

Singh believes this study will help move the field of macular degeneration research toward developing new drugs that target RPE , while providing a new and improved to screen those drugs. Though this work is early, the team hopes it will lead to an effective treatment for in the future.

Explore further: Study suggests stem cells may repair dying retinal cells

More information: Drusen in patient-derived hiPSC-RPE models of macular dystrophies, Proceedings of the National Academy of Sciences (2017). DOI: 10.1073/pnas.1710430114 , http://www.pnas.org/content/early/2017/09/01/1710430114

Related Stories

Study suggests stem cells may repair dying retinal cells

January 21, 2016
Researchers at St. Erik Eye Hospital and Karolinska Institutet have for the first time successfully transplanted human retinal pigment epithelial cells derived from stem cells into eyes that are similar to human eyes. The ...

Levodopa shows promise against macular degeneration

November 13, 2015
(HealthDay)— Levodopa (L-dopa) might hold potential for preventing or treating macular degeneration, according to a study published online Oct. 30 in The American Journal of Medicine.

Study shows daily aspirin intake can lead to blindness

October 5, 2011
(Medical Xpress) -- A new study published in Ophthalmology reveals that while taking a daily aspirin may reduce the risks of heart disease and stroke, a disturbing side effect has also been noted to increase the risk of developing ...

Clinical trial tests cord-blood cells to treat macular degeneration

July 20, 2016
UIC is part of a national phase 2 clinical trial to evaluate the safety and tolerability of using cells derived from multipotent umbilical cord cells to treat age-related macular degeneration, the most common cause of vision ...

Stem cell injection may soon reverse vision loss due to age-related macular degeneration

April 14, 2015
An injection of stem cells into the eye may soon slow or reverse the effects of early-stage age-related macular degeneration, according to new research from scientists at Cedars-Sinai. Currently, there is no treatment that ...

Drusen as promising biomarkers for progression of macular degeneration

June 7, 2017
Age-Related Macular Degeneration (AMD) is a common disease of the centre of the retina, primarily affecting those aged over 50. The first signs of the disease are so-called drusen, which occur under the retina in the form ...

Recommended for you

Inflammation trains the skin to heal faster

October 18, 2017
Scars may fade, but the skin remembers. New research from The Rockefeller University reveals that wounds or other harmful, inflammation-provoking experiences impart long-lasting memories to stem cells residing in the skin, ...

Large variety of microbial communities found to live along female reproductive tract

October 18, 2017
(Medical Xpress)—A large team of researchers from China (and one each from Norway and Denmark) has found that the female reproductive tract is host to a far richer microbial community than has been thought. In their paper ...

Study of what makes cells resistant to radiation could improve cancer treatments

October 18, 2017
A Johns Hopkins University biologist is part of a research team that has demonstrated a way to size up a cell's resistance to radiation, a step that could eventually help improve cancer treatments.

New approach helps rodents with spinal cord injury breathe on their own

October 17, 2017
One of the most severe consequences of spinal cord injury in the neck is losing the ability to control the diaphragm and breathe on one's own. Now, investigators show for the first time in laboratory models that two different ...

Pair of discoveries illuminate new paths to flu and anthrax treatments

October 17, 2017
Two recent studies led by biologists at the University of California San Diego have set the research groundwork for new avenues to treat influenza and anthrax poisoning.

New method to measure how drugs interact

October 17, 2017
Cancer, HIV and tuberculosis are among the many serious diseases that are frequently treated with combinations of three or more drugs, over months or even years. Developing the most effective therapies for such diseases requires ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.